Rebranding
Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity FOR DEBATE Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity Ezio Bonifacio1,2 & Chantal Mathieu3 & Gerald T. Nepom4 & Anette-G. Ziegler5,6 & Henry Anhalt7 & Michael J. Haller8 & Leonard C. Harrison9,10
https://www.gppad.lu.se/sites/gppad.lu.se/files/2025-05/Rebranding.pdf - 2026-01-07
